Lactotripeptides and antihypertensive effects: a critical review
Authors:
Open Access
- 5 December 2008
- journal article
- review article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 101 (6) , 776-786
Abstract
Hypertension or high blood pressure is a significant health problem worldwide. Typically, lifestyle changes, including adopting a healthy diet, are recommended for people with an elevated blood pressure. Lactotripeptides are bioactive milk peptides with potential antihypertensive properties in man. These peptides, as part of a food product or as nutraceutical, may contribute to the prevention and treatment of hypertension. This paper reviews the current evidence of the blood pressure control properties of lactotripeptides in man. Blood pressure-lowering effects of lactotripeptides are typically measured after 4–6 weeks of treatment. However, in some cases, a blood pressure response has been observed after 1–2 weeks. Maximum blood pressure reductions approximate 13 mmHg (systolic blood pressure) and 8 mmHg (diastolic blood pressure) after active treatment compared with placebo, and are likely reached after 8–12 weeks of treatment. Effective dosages of lactotripeptides range from 3·07 to 52·5 mg/d. Evidence indicates that lactotripeptides are only effective at elevated blood pressure; no further lowering of normal blood pressure has been observed. Concomitant intake of antihypertensive medication does not seem to influence the potency of lactotripeptides to lower blood pressure. Similarly, ethnicity has not been found to influence the extent of lactotripeptide-induced blood pressure lowering. Based on the currently available data, lactotripeptides appear to be safe and effective. Thus, they can be part of a healthy diet and lifestyle to prevent or reduce high blood pressure.Keywords
This publication has 54 references indexed in Scilit:
- The Impact of Obesity on Cardiovascular Disease Risk Factors and Subclinical Vascular DiseaseArchives of internal medicine (1960), 2008
- Dietary Phosphorus and Blood PressureHypertension, 2008
- Lactotripeptides Show No Effect on Human Blood PressureHypertension, 2008
- Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjectsBritish Journal of Clinical Pharmacology, 2006
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertensionJournal Of Hypertension, 2003
- Hypotensive Effects of Sour Milk in Subjects with Mild or Moderate Hypertension.Nippon Eiyo Shokuryo Gakkaishi, 2001
- α-Lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive ratsLife Sciences, 2000
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990